Hypothesis

Core claim: In aged tissues, a subset of senescent myeloid‑derived suppressor cells (MDSCs) functions as a short‑lived "emergency reserve" that, via NLRP3‑driven IL‑1β and IL‑6 secretion, primes hematopoietic stem and progenitor cells (HSPCs) to undergo emergency myelopoiesis. This transient boost enhances innate immune responsiveness to acute challenges (e.g., infection, tissue injury) but becomes maladaptive when the senescent MDSC pool persists, fueling chronic immunosuppression.

Mechanistic rationale

• Senescent MDSCs exhibit high p21 and secrete IL‑1β through active NLRP3 inflammasome [NLRP3 inflammasome activation drives senescence through IL-1β secretion].
• Their SASP also contains IL‑6, which acts on MDSCs themselves via MAPK to sustain their immunosuppressive phenotype [IL-6 promotes the proliferation and immunosuppressive function of myeloid-derived suppressor cells via MAPK signaling]
• IL‑6 and IL‑1β are known to stimulate HSPC proliferation and myeloid bias through STAT3 and NF‑κB pathways, a process documented in emergency myelopoiesis [Emergency myelopoiesis is driven by IL‑6 and IL‑1β signaling in HSPCs]
• Thus, senescent MDSCs create a paracrine loop that temporarily expands granulocyte‑monocyte progenitors, increasing neutrophil and inflammatory monocyte output.

Predictions and falsifiability

1. Transient NLRP3 inhibition in aged mice after LPS challenge will reduce emergency granulopoiesis and worsen bacterial clearance, whereas senolytic removal of senescent MDSCs will have the same effect.

   • Test: Treat aged C57BL/6 mice with MCC950 (NLRP3 inhibitor) or a senolytic (e.g., dasatinib+quercetin) 2 h before intraperitoneal LPS (5 mg/kg). Measure bone‑marrow CFU‑GEMM, blood neutrophils at 6 h, and survival after sub‑lethal Listeria monocytogenes infection 24 h later.
   • Falsification: If inhibition improves survival or neutrophil counts, the hypothesis is refuted.

2. Adoptive transfer of purified senescent MDSCs (p21^high, IL‑1β^high) into young, NLRP3‑competent recipients will augment emergency myelopoiesis and improve survival after sepsis, an effect blocked by neutralizing IL‑6 or IL‑1β antibodies.

   • Test: Isolate senescent MDSCs from old mice (p21^high, SA‑β‑gal^+, IL‑1β^+), inject 1 × 10^6 cells into young recipients, then challenge with cecal ligation and puncture. Compare neutrophil influx, cytokine storm, and mortality.
   • Falsification: No improvement or worsened outcome refutes the protective role.

3. Chronic persistence of senescent MDSCs correlates with diminished HSPC responsiveness to acute IL‑6/IL‑1β spikes, indicating a shift from beneficial to detrimental signaling.

   • Test: Serial bone‑marrow transplants from old mice into young recipients; assess HSPC STAT3 phosphorylation after ex‑vivo IL‑6 stimulation. Expect blunted response in grafts with high senescent MDSC burden.
   • Falsification: Preserved or heightened HSPC signaling despite senescence load contradicts the model.

Therapeutic implication

If senescent MDSCs provide a short‑term innate‑immune boost, indiscriminate senolytic use during acute infection or post‑surgical trauma could remove this safety net, increasing susceptibility to secondary infections. A refined strategy would time senolytic administration to the resolution phase of inflammation, preserving the early emergency reserve while clearing the chronic immunosuppressive load.

References (inline)

• NLRP3 inflammasome activation drives senescence through IL-1β secretion: NLRP3 inflammasome activation drives senescence through IL-1β secretion
• IL-6 promotes MDSC proliferation and immunosuppressive function via MAPK: IL-6 promotes the proliferation and immunosuppressive function of myeloid-derived suppressor cells via MAPK signaling
• IL-6 and p21‑high senescent states in beneficial tissue reprogramming: IL-6 and p21-high senescent states participate in beneficial tissue reprogramming
• Senescent fibroblasts impair anti‑tumor immunity: Senescent fibroblasts impair anti-tumor immunity by recruiting and activating immunosuppressive myeloid cells
• Age‑related systemic NLRP3 activity drives functional decline: Age-related systemic NLRP3 inflammasome activity drives functional decline
• Emergency myelopoiesis driven by IL‑6/IL‑1β in HSPCs: Emergency myelopoiesis is driven by IL‑6 and IL‑1β signaling in HSPCs